Brief: Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market
05/09/2025 16:31
Sept 5 (Reuters) - Gelteq Ltd GELS.O: GELTEQ ANNOUNCES COMMENCEMENT OF PRECLINICAL TRIAL FOR NOVEL GEL-BASED ANTIHISTAMINE FORMULATION TARGETING ALLERGY MARKET GELTEQ LTD - PLANS HUMAN TRIALS FOR FDA APPROVAL Source text: ID:nGNX2qvvc1 Further company coverage: GELS.O ((Reuters.Briefs@thomsonreuters.com;))